Search details
1.
The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study).
Turk Kardiyol Dern Ars
; 50(8): 568-575, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36317659
Results
1 -
1
de 1
1
Next >
>>